Invasive Group A Streptococcal Infection

Launched by ASSOCIATION CLINIQUE THÉRAPEUTIQUE INFANTILE DU VAL DE MARNE · Mar 16, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a serious infection caused by Group A Streptococcus, a type of bacteria that can lead to severe health issues like sepsis in children. The researchers want to learn more about how this infection affects young patients, including the reasons why some children get very sick while others do not. This study will look back at past cases and also observe new cases as they happen in hospitals.

To participate in this trial, children must be under 18 years old and have a confirmed diagnosis of an invasive Group A Streptococcus infection. This means the bacteria must be found in a part of the body that is usually free of germs, or in cases of severe illness like toxic shock syndrome. Parents or guardians who are interested in this study should know that they will need to give permission for their child to participate. This trial aims to gather important information that could help improve treatments and outcomes for children facing this dangerous infection.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age\<18 years
• • Documented invasive Group A Streptococcus infection (identification of GAS in a normally sterile site or from another site in case of toxin shock or necrotizing dermo-hypodermatitis)
• Exclusion Criteria:
• • Opposition of the patient or his/her legal representative